Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE

Director EchocardiographyProfessor of Medicine, College of Medicine

Mayo Clinic, Scottsdale, Arizona

ASSESSMENT OF CAROTID ATHEROSCLEROSIS IN MY CLINICAL PRACTICE

Carotid Bifurcation US Femoral Bifurcation US

Arterial Segments Commonly Involved in Atherosclerosis

Subclinical Atherosclerosis

Adapated from Naqvi TZ, Lee MS. JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38

Value in Clinical Practice

53 yr old male T chol: 251HDL 53LDL 167TG 70Framingham risk:11%

Case

61 yr old female Total cholesterol 216HDL 50LDL 143Triglycerides 239 mg/dlFRS 6%

Case

Case: My patient is not compliant..

50 yr old Caucasian female, history of DM, non compliant with diet or lipid lowering agents

Case: 45 year old maleHTN,h/o of RCA stent 3 yrs ago,

-ve stress echoWould not take statins

Case: 45 year old male

HTN,h/o of RCA stent 3 yrs ago, -ve stress

echoWould not take statins

Case: I am Intolerant to Statins and Would not

take’m67 MCABGInf MI, EF 40%Recent LCX Stent

Naqvi TZ. J Am Soc Echocardiogr. 2015 May; 28(5):A16-7

Summary

CIMT and plaque imaging is feasible in clinical practice in primary prevention setting and can improve CVD risk prediction over conventional methods

CIMT and plaque imaging can detect atherosclerosis burden in secondary prevention setting and improve patient compliance

Common Carotid

naqvi.tasneem@mayo.edu